BackElliptic Laboratories ASA Overview

Elliptic Laboratories ASA Receivables

Latest receivables for ELABS.OL: $79M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$78.81M
↓ 26.21% YoYΔ $-28.00M vs prior year quarter

Peer trimmed avg / median

Loading

Elliptic Laboratories ASA Receivables History

Loading

Elliptic Laboratories ASA vs. peers: Receivables Comparison

Loading

Elliptic Laboratories ASA Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Elliptic Laboratories ASA (ELABS.OL) FAQ

Elliptic Laboratories ASA (ELABS.OL) currently reports a receivables of $79M as of June 2026. That compares with $110M in the prior-year period — down 26.2% year over year. Use the charts on this page to explore Elliptic Laboratories ASA's receivables history and peer comparisons.

Elliptic Laboratories ASA's receivables decreased from $110M to $79M — a 26.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Elliptic Laboratories ASA reported $79M in receivables as of June 2026. That compares with $110M in the prior-year period — down 26.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $79M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Elliptic Laboratories ASA, and consider following ELABS.OL for alerts when major investors trade the stock.